Fisher MD. Perioperative cardiac dysrhythmias. Anesthesiology. 1997;86:1397-1424.

Atlee JL. Perioperative cardiac dysrhythmias: Diagnosis and management. Anesthesiology. 1997;86:1397-424.

Amar D, Zhang H, Roistacher N. The incidence and outcome of ventricular arrhythmias after noncardiac thoracic surgery. Anesth Analg. 2002;95:537-543.

Amar D. Postthoracotomy atrial fibrillation. Curr Opin Anaesthesiol. 2007;20:43-47.

Tripi P, Dorostkar P. Case report: Automatic atrial tachycardia in an infant following general anesthesia. Paediatr Anaesth. 2005;15:158-161.

Balser JR. Perioperative dysrhythmias. 2000;twenty-eight:1-13.

Thompson A, Balser JR. Perioperative cardiac arrhythmias. Br J Anaesth. 2004;93:86-94.

Antzelevitch C. Hetergeneity of cellular repolarization of LTQS: The role of M cells. Eur Heart J. 2001;3:K2-K16.

Santambrogioa L, Braschib A. Conduction abnormalities and anaesthesia. Curr Opin Anaesthesiol. 2007;20:269-273.

Wahr JA, Parks R, Boisvert D. Preoperative serum potassium levels and perioperative outcomes in cardiac surgery patients: Multicenter Study of Perioperative Ischemia Research Group. JAMA. 1999;281:2203-2210.

Prielipp RC, Zaloga GP, Butterworth JF. Magnesium inhibits the hypertensive but not the cardiotonic actions of low-dose epinephrine (see comments). Anesthesiology. 1991;74:973-979.

England MR, Gordon G, Salem M. Magnesium administration and dysrhythmias after cardiac surgery. JAMA. 1992;268:2395-2402.

Wilkes NJ, Mallett SW, Peachey T. Correction of Ionized Plasma Magnesium During Cardiopulmonary Bypass Reduces the Risk of Postoperative Cardiac Arrhythmia. Anesth Analg. 2002;95:828-834.

James MF, Beer RE, Esser JD. Intravenous magnesium sulfate inhibits catecholamine release associated with tracheal intubation. Anesth Analg. 1989;68:772-776.

Mayer DB, Miletich DJ, Feld JM. The effects of magnesium salts on the duration of epinephrine-induced ventricular tachyarrhythmias in anesthetized rats. Anesthesiology. 1989;71:923-928.

James MFM. Magnesium: an emerging drug in anaesthesia. British Journal of Anaesthesia. 2009;103(4):465-467.

2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2005;112(IV^sIV):72-84.

Marill KA, Wolfram S, Souza IS. Adenosine for wide-complex tachycardia: Efficacy and safety. Crit Care Med. 2009;37:2512-2518.

Lorentz MN, Ramiro FGC. Anestesia e síndrome do QT longo. Rev Bras Anestesiol. 2007;57(5):543-548.

Booker PD. Long QT syndrome and anaesthesia. Br J Anaesth. 2003;90:349-366.

Drew BJ, Ackerman MJ, Funk M. Prevention of torsade de pointes in hospital settings: A scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2010;121:1047-1060.

Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350:1013-1022.

Molokhia M, Pathak A, Lapeyre-Mestre M. Case ascertainment and estimated incidence of drug-induced long-QT syndrome: Study in Southwest France. Br J Clin Pharmacol. 2008;66:386-395.

Freeman BD, Dixon DJ, Coopersmith CM. Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients. Pharmacoepidemiol Drug Saf. 2008;17:971-981.

Kannankeril PJ, Roden DM. Drug-induced long QT and torsade de pointes: Recent advances. Curr Opin Cardiol. 2007;22:39-43.

Lin YL, Kung MF. Magnitude of QT prolongation associated with a higher risk of torsades de pointes. Pharmacoepidemol Drug Saf. 2009;18:235-239.

Desai M, Li L, Desta Z. Variability of heart rate correction methods for the QT interval. Br J Clin Pharmacol. 2003;55:511-517.

Chaudhry GM, Haffajee CI. Antiarrhythmic agents and proarrhythmia. Crit Care Med. 2000;28(^sSuppl):N158-N164.

Vaughan Williams EM. A classification of antiarrhrytmic action reassessed after a decade of new drugs. J Clin Pharmacol. 1984;24:129-147.

Singh BN. Current antiarrhythmic drugs: An overview of mechanisms of action and potential clinical utility. J Cardiovasc Electrophysiol. 1999;10:283-301.

Barnes BJ, Hollands JM. Drug-induced arrhythymias. Crit Care Med. 2010;38(^sSuppl):S188 -S197.

Charbit B, Funck-Brentano C. Droperidol-induced Proarrhythmia: The Beginning of an Answer?. Anesthesiology. 2007;107:531-536.

Atlee JL. Cardiac arrhythmias: drugs and devices. Curr Opin Anaesthesiol. 2001;14:3-9.

Harasawa R, Hayashi Y, Iwasaki M. Bolus administration of landiolol, a short-acting, selective b1-blocker, to treat tachycardia during anesthesia: a dose-dependent study. J Cardiothorac Vasc Anesth. 2006;20:793-795.

Chrysostomou C, Beerman L, Shiderly D. Dexmedetomidine: a novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study. Anesth Analg. 2008;107:1514-1522.

Liebold A, Wahba A, Birnbaun DE. Low-energy cardioversion with epicardial wire electrodes: new treatment of atrial fibrillation after open heart surgery. Circulation. 1998;98:883-886.

Dellekarth G, Geppert A, Neunteufl T. Amiodarone versus diltiazen for rate control in critical ill patients with atrial tachyarrhythmias. Crit Care Med. 2001;29:1149-1153.

Galve E, Rius T, Ballester R. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study. J Am Coll Cardiol. 1996;27:1079-1082.

Blanchard L, Collard CD. Non-antiarrhythmic agents for prevention of postoperative atrial fibrillation: role of statins. Curr Opin Anaesthesiol. 2007;20:53-56.

Beaulieu Y, Denault A, Couture P. Perioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in patients undergoing cardiac valvular surgery. Anesthesiology. 2010;112:128-137.

Rea RS, Kane-Gill SL, Rudis MI. Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias. Crit Care Med. 2006;34:1617-1623.

Amar D. Prevention and Management of Perioperative Arrhythmias in the Thoracic Surgical Population. Anesthesiology Clin. 2008;26:325-335.